OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 41 filers reported holding OPIANT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $234,000 | -47.3% | 21,730 | -41.4% | 0.00% | 0.0% |
| Q2 2022 | $444,000 | -46.6% | 37,056 | -4.6% | 0.00% | -50.0% |
| Q1 2022 | $832,000 | -61.4% | 38,832 | -39.4% | 0.00% | -60.0% |
| Q4 2021 | $2,154,000 | +63.9% | 64,057 | +25.5% | 0.01% | +66.7% |
| Q3 2021 | $1,314,000 | – | 51,045 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 210,000 | $2,518,000 | 5.80% |
| APIS CAPITAL ADVISORS, LLC | 196,000 | $2,350,000 | 2.65% |
| Stonepine Capital Management, LLC | 152,278 | $1,826,000 | 0.85% |
| Parkman Healthcare Partners LLC | 75,632 | $907,000 | 0.33% |
| PERRITT CAPITAL MANAGEMENT INC | 30,500 | $366,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 50,405 | $604,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 126,978 | $1,523,000 | 0.01% |
| Trexquant Investment LP | 12,219 | $147,000 | 0.01% |
| Renaissance Technologies | 193,415 | $2,319,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 74,400 | $892,000 | 0.00% |